A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.
暂无分享,去创建一个
I. Holme | K. Tveter | S. Sander | S. Hagen | O. Klepp | C. Poulsen | T. Urnes | S. Sivertsen | O. Muri | S. Kloster